论文部分内容阅读
一、谈判进展和焦点问题根据TRIPs的有关条款,各国为解决公共健康危机可授予药品强制许可。但TRIPs第31条(f)又规定,依强制许可生产的药品应当主要供应国内市场,使处于公共健康危机中没有或缺乏充分药品制造能力的
I. Progress in Negotiation and Focus Issues According to the relevant provisions of TRIPs, countries may grant drug compulsory licenses to solve the public health crisis. Article 31 (f) of the TRIPs, in turn, stipulates that pharmaceutical products manufactured under compulsory licenses should be mainly supplied to the domestic market so that drugs that are not in a crisis of public health or that lack sufficient pharmaceutical manufacturing capacity